![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
American Oriental Bioengineering, Inc. | NYSE:AOB | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.52 | 0.00 | 01:00:00 |
Read
attached instruction sheet before preparing form. Please Print
or Type.
Nothing
in this form shall be construed to imply that the Commission has verified
any information contained herein.
|
If
the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
|
Full
Name of Registrant
|
American
Oriental Bioengineering, Inc.
|
Former
Name if Applicable
|
Address
of Principal Executive Office
(Street and
Number)
|
1
Liangshuihe First Avenue, Beijing E-Town Economic and Technology
Development Area, E-Town
|
City,
State and Zip Code
|
Beijing
100176, People’s Republic of China
|
x
|
(a)
The reasons described in reasonable detail in Part III of this form could
not be eliminated without unreasonable effort or expense;
(b)
The subject annual report, semi-annual report, transition report on Form
10-K, Form 20-F, 11-K, Form N-SAR or From N-CSR, or portion thereof, will
be filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report of transition report on Form
10-Q, or portion thereof will be filed on or before the fifth calendar day
following the prescribed due date; and
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
|||
Mitchell
S. Nussbaum, Esq.
|
212
|
407-4159
|
||
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
||
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months (or for such shorter) period
that the registrant was required to file such reports) been
filed? If answer is no, identify report(s).
|
x
Yes
¨
No
|
||
(3)
|
Is
it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
|
o
Yes
x
No
|
||
If
so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
|
||||
American
Oriental Bioengineering, Inc.
|
(Name
of Registrant as Specified in
Charter)
|
Date:
November 9, 2009
|
By:
/s/ Tony
Liu
Name: Tony
Liu
Title: Chief
Executive Officer and Chairman
|
1 Year American Oriental Bioengineering, Inc. Chart |
1 Month American Oriental Bioengineering, Inc. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions